{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:22:48Z","timestamp":1772684568228,"version":"3.50.1"},"reference-count":96,"publisher":"Institute of Physiology of the Czech Academy of Sciences","issue":"5\/2024","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder that includes non-alcoholic hepatic steatosis without or with moderate inflammation and non-alcoholic steatohepatitis (NASH), characterized by necroinflammation and a more rapid progression of fibrosis. It is the primary pathological basis for hepatocellular carcinoma. With its prevalence escalating annually, NAFLD has emerged as a global health epidemic, presenting a significant hazard to public health worldwide. Existing studies have shown that physical activity and exercise training have a positive effect on NAFLD. However, the extent to which exercise improves NAFLD depends on the type, intensity, and duration. Therefore, the type of exercise that has the best effect on improving NAFLD remains to be explored. To date, the most valuable discussions involve aerobic and anaerobic exercise. Exercise intervenes in the pathological process of NAFLD by regulating physiological changes in cells through multiple signaling pathways. The review aims to summarize the signaling pathways affected by two different exercise types associated with the onset and progression of NAFLD. It provides a new basis for improving and managing NAFLD in clinical practice.<\/jats:p>","DOI":"10.33549\/physiolres.935244","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:47:03Z","timestamp":1731415623000},"page":"671-686","source":"Crossref","is-referenced-by-count":5,"title":["The Impact of Aerobic and Anaerobic Exercise Interventions on the Management and Outcomes of Non-Alcoholic Fatty Liver Disease"],"prefix":"10.33549","author":[{"given":"F","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.\tPowell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397:2212-2224. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3","DOI":"10.1016\/s0140-6736(20)32511-3"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.\tPouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, ET AL. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 2022;22:63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tProvencher DM. An update on nonalcoholic fatty liver disease. JAAPA 2014;27:18-22. https:\/\/doi.org\/10.1097\/01.JAA.0000450801.19545.93","DOI":"10.1097\/01.JAA.0000450801.19545.93"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.\tYounossi ZM, Corey KE, Lim JK. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 2021;160:912-918. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.051","DOI":"10.1053\/j.gastro.2020.11.051"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.\tTanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res 2020;2020:3920196. https:\/\/doi.org\/10.1155\/2020\/3920196","DOI":"10.1155\/2020\/3920196"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.\tChalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328-357. https:\/\/doi.org\/10.1002\/hep.29367","DOI":"10.1002\/hep.29367"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.\t\u0160m\u00edd V, Dvo\u0159\u00e1k K, \u0160ediv\u00fd P, Kosek V, Len\u00ed\u010dek M, Dezortov\u00e1 M, Haj\u0161lov\u00e1 J, ET AL. Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD. Hepatol Commun 2022;6:1336-1349. https:\/\/doi.org\/10.1002\/hep4.1906","DOI":"10.1002\/hep4.1906"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.\tAthyros VG, Boutari C, Stavropoulos K, Anagnostis P, Imprialos KP, Doumas M, Karagiannis A. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. Curr Vasc Pharmacol 2018;16:246-253. https:\/\/doi.org\/10.2174\/1570161115666170621082910","DOI":"10.2174\/1570161115666170621082910"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.\tNiu S, Chen S, Chen X, Ren Q, Yue L, Pan X, Zhao H, Li Z, Chen X. Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model. Front Endocrinol (Lausanne) 2022;13:1046130. https:\/\/doi.org\/10.3389\/fendo.2022.1046130","DOI":"10.3389\/fendo.2022.1046130"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.\tLoomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537-2564. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.\tRinella ME, Sanyal AJ. NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD. Nat Rev Gastroenterol Hepatol 2015;12:65-66. https:\/\/doi.org\/10.1038\/nrgastro.2014.232","DOI":"10.1038\/nrgastro.2014.232"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.\tThorp A, Stine JG. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep 2020;19:402-411. https:\/\/doi.org\/10.1007\/s11901-020-00543-9","DOI":"10.1007\/s11901-020-00543-9"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.\tKistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011;106:460-468; quiz 469. https:\/\/doi.org\/10.1038\/ajg.2010.488","DOI":"10.1038\/ajg.2010.488"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.\tNath P, Panigrahi MK, Sahu MK, Narayan J, Sahoo RK, Patra AA, Jena S, ET AL. Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise. J Clin Transl Hepatol 2020;8:120-126. https:\/\/doi.org\/10.14218\/JCTH.2019.00012","DOI":"10.14218\/jcth.2019.00012"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.\tWinn NC, Liu Y, Rector RS, Parks EJ, Ibdah JA, Kanaley JA. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial. Metabolism 2018;78:128-140. https:\/\/doi.org\/10.1016\/j.metabol.2017.08.012","DOI":"10.1016\/j.metabol.2017.08.012"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.\tGolabi P, Locklear CT, Austin P, Afdhal S, Byrns M, Gerber L, Younossi ZM. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. World J Gastroenterol 2016;22:6318-6327. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6318","DOI":"10.3748\/wjg.v22.i27.6318"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.\tShojaee-Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, Bell J, ET AL. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD. J Clin Endocrinol Metab 2016;101:4219-4228. https:\/\/doi.org\/10.1210\/jc.2016-2353","DOI":"10.1210\/jc.2016-2353"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.\tZhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, ET AL. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Intern Med 2016;176:1074-1082. https:\/\/doi.org\/10.1001\/jamainternmed.2016.3202","DOI":"10.1001\/jamainternmed.2016.3202"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.\tDela F, Prats C, Helge JW. Exercise interventions to prevent and manage type 2 diabetes: physiological mechanisms. Med Sport Sci 2014;60:36-47. https:\/\/doi.org\/10.1159\/000357334","DOI":"10.1159\/000357334"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.\tJohnson NA, George J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010;52:370-381. https:\/\/doi.org\/10.1002\/hep.23711","DOI":"10.1002\/hep.23711"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.\tKeating SE, Hackett DA, Parker HM, O'Connor HT, Gerofi JA, Sainsbury A, Baker MK, ET AL. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol 2015;63:174-182. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.022","DOI":"10.1016\/j.jhep.2015.02.022"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.\tRector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, Ibdah JA. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 2008;294:G619-G626. https:\/\/doi.org\/10.1152\/ajpgi.00428.2007","DOI":"10.1152\/ajpgi.00428.2007"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.\tKwak MS, Kim D. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. Korean J Intern Med 2018;33:64-74. https:\/\/doi.org\/10.3904\/kjim.2017.343","DOI":"10.3904\/kjim.2017.343"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.\tSullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012;55:1738-1745. https:\/\/doi.org\/10.1002\/hep.25548","DOI":"10.1002\/hep.25548"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.\tFealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ, Kirwan JP. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol (1985) 2012;113:1-6. https:\/\/doi.org\/10.1152\/japplphysiol.00127.2012","DOI":"10.1152\/japplphysiol.00127.2012"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.\tGao LL, Ma JM, Fan YN, Zhang YN, Ge R, Tao XJ, Zhang MW, Gao QH, Yang JJ. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. Int J Biol Macromol 2021;183:1379-1392. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.066","DOI":"10.1016\/j.ijbiomac.2021.05.066"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.\tCigrovski Berkovic M, Bilic-Curcic I, Mrzljak A, Cigrovski V. NAFLD and Physical Exercise: Ready, Steady, Go. Front Nutr 2021;8:734859. https:\/\/doi.org\/10.3389\/fnut.2021.734859","DOI":"10.3389\/fnut.2021.734859"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.\tGuo J, Zhang Y, Mihic A, Li SH, Sun Z, Shao Z, Wu J, Weisel RD, Li RK. A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation. Cardiovasc Res 2015;105:383-393. https:\/\/doi.org\/10.1093\/cvr\/cvv010","DOI":"10.1093\/cvr\/cvv010"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.\tChu M, Liu H, Xiong Z, Ju C, Zhao L, Li K, Tian S, Gu P. Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinson's Disease via the AKT\/GSK3\u03b2 Pathway. Curr Neurovasc Res 2021;18:102-112. https:\/\/doi.org\/10.2174\/1567202618666210531141833","DOI":"10.2174\/1567202618666210531141833"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.\tHatta K, Guo J, Ludke A, Dhingra S, Singh K, Huang ML, Weisel RD, Li RK. Expression of CNPY2 in mouse tissues: quantification and localization. PLoS One 2014;9:e111370. https:\/\/doi.org\/10.1371\/journal.pone.0111370","DOI":"10.1371\/journal.pone.0111370"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.\tKitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, ET AL. Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis. World J Gastroenterol 2009;15:5193-5199. https:\/\/doi.org\/10.3748\/wjg.15.5193","DOI":"10.3748\/wjg.15.5193"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.\tHong F, Liu B, Wu BX, Morreall J, Roth B, Davies C, Sun S, Diehl JA, Li Z. CNPY2 is a key initiator of the PERK-CHOP pathway of the unfolded protein response. Nat Struct Mol Biol 2017;24:834-839. https:\/\/doi.org\/10.1038\/nsmb.3458","DOI":"10.1038\/nsmb.3458"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.\tLiu C, Liu Y, He J, Mu R, Di Y, Shen N, Liu X, ET AL. Liraglutide Increases VEGF Expression via CNPY2-PERK Pathway Induced by Hypoxia\/Reoxygenation Injury. Front Pharmacol 2019;10:789. https:\/\/doi.org\/10.3389\/fphar.2019.00789","DOI":"10.3389\/fphar.2019.00789"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.\tLi J, Huang L, Xiong W, Qian Y, Song M. Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway. Biochem Biophys Res Commun 2022;603:35-40. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.008","DOI":"10.1016\/j.bbrc.2022.03.008"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.\tPaquette M, El-Houjeiri L, C Zirden L, Puustinen P, Blanchette P, Jeong H, Dejgaard K, Siegel PM, Pause A. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy 2021;17:3957-3975. https:\/\/doi.org\/10.1080\/15548627.2021.1898748","DOI":"10.1101\/2021.01.27.428292"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.\tZhou F, Ding M, Gu Y, Fan G, Liu C, Li Y, Sun R, ET AL. Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways. Front Pharmacol 2021;12:826628. https:\/\/doi.org\/10.3389\/fphar.2021.826628","DOI":"10.3389\/fphar.2021.826628"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.\tKo JR, Seo DY, Park SH, Kwak HB, Kim M, Ko KS, Rhee BD, Han J. Aerobic exercise training decreases cereblon and increases AMPK signaling in the skeletal muscle of STZ-induced diabetic rats. Biochem Biophys Res Commun 2018;501:448-453. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.009","DOI":"10.1016\/j.bbrc.2018.05.009"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.\tde Lima EA, de Sousa L, de S Teixeira AA, Marshall AG, Zanchi NE, Neto J. Aerobic exercise, but not metformin, prevents reduction of muscular performance by AMPk activation in mice on doxorubicin chemotherapy. J Cell Physiol 2018;233:9652-9662. https:\/\/doi.org\/10.1002\/jcp.26880","DOI":"10.1002\/jcp.26880"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.\tLi DD, Ma JM, Li MJ, Gao LL, Fan YN, Zhang YN, Tao XJ, Yang JJ. Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK\/PPAR\u03b1\/PGC-1\u03b1 Pathway. Nutrients 2022;14:3247. https:\/\/doi.org\/10.3390\/nu14153247","DOI":"10.3390\/nu14153247"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.\tLiu W, Wang Z, Xia Y, Kuang H, Liu S, Li L, Tang C, Yin D. The balance of apoptosis and autophagy via regulation of the AMPK signal pathway in aging rat striatum during regular aerobic exercise. Exp Gerontol 2019;124:110647. https:\/\/doi.org\/10.1016\/j.exger.2019.110647","DOI":"10.1016\/j.exger.2019.110647"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41.\tMcConell GK, Lee-Young RS, Chen ZP, Stepto NK, Huynh NN, Stephens TJ, Canny BJ, Kemp BE. Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen. J Physiol 2005;568:665-676. https:\/\/doi.org\/10.1113\/jphysiol.2005.089839","DOI":"10.1113\/jphysiol.2005.089839"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42.\tWojtaszewski JF, Mourtzakis M, Hillig T, Saltin B, Pilegaard H. Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 2002;298:309-316. https:\/\/doi.org\/10.1016\/S0006-291X(02)02465-8","DOI":"10.1016\/s0006-291x(02)02465-8"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.\tHasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, ET AL. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Proc Natl Acad Sci U S A 2015;112:E1624-E1631. https:\/\/doi.org\/10.1073\/pnas.1419502112","DOI":"10.1073\/pnas.1419502112"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44.\tMontagner A, Polizzi A, Fouch\u00e9 E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, ET AL. Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 2016;65:1202-1214. https:\/\/doi.org\/10.1136\/gutjnl-2015-310798","DOI":"10.1136\/gutjnl-2015-310798"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.\tZou Y, Chen Z, Sun C, Yang D, Zhou Z, Peng X, Zheng L, Tang C. Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1\/AMPK\/NRF2 Signaling. Int J Mol Sci 2021;22:10940. https:\/\/doi.org\/10.3390\/ijms222010940","DOI":"10.3390\/ijms222010940"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.\tBai Y, Li T, Liu J, Wang Y, Wang C, Ju S, Zhou C, ET AL. Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress. Eur J Nutr 2023;62:2621-2632. https:\/\/doi.org\/10.1007\/s00394-023-03179-9","DOI":"10.1007\/s00394-023-03179-9"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47.\tGuarino M, Kumar P, Felser A, Terracciano LM, Guix\u00e9-Muntet S, Humar B, Foti M, ET AL. Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. Cancers (Basel) 2020;12:1407. https:\/\/doi.org\/10.3390\/cancers12061407","DOI":"10.3390\/cancers12061407"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.\tMcLelland GL, Lopez-Osias M, Verzijl C, Ellenbroek BD, Oliveira RA, Boon NJ, Dekker M, et al. Identification of an alternative triglyceride biosynthesis pathway. Nature 2023;621:171-178. https:\/\/doi.org\/10.1038\/s41586-023-06497-4","DOI":"10.1038\/s41586-023-06497-4"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49.\tLee YJ, Ko EH, Kim JE, Kim E, Lee H, Choi H, Yu JH, ET AL. Nuclear receptor PPAR\u03b3-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc Natl Acad Sci U S A 2012;109:13656-13661. https:\/\/doi.org\/10.1073\/pnas.1203218109","DOI":"10.1073\/pnas.1203218109"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50.\tBaek KW, Gim JA, Park JJ. Regular moderate aerobic exercise improves high-fat diet-induced nonalcoholic fatty liver disease via monoacylglycerol O-acyltransferase 1 pathway suppression. J Sport Health Sci 2020;9:472-478. https:\/\/doi.org\/10.1016\/j.jshs.2018.09.001","DOI":"10.1016\/j.jshs.2018.09.001"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51.\tYu JH, Song SJ, Kim A, Choi Y, Seok JW, Kim HJ, Lee YJ, Lee KS, Kim JW. Suppression of PPAR\u03b3-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis. Sci Rep 2016;6:29352. https:\/\/doi.org\/10.1038\/srep29352","DOI":"10.1038\/srep29352"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52.\tLiss K, Ek SE, Lutkewitte AJ, Pietka TA, He M, Skaria P, Tycksen E, ET AL. Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia\/Reperfusion Injury in Mice With Hepatic Steatosis. Liver Transpl 2021;27:116-133. https:\/\/doi.org\/10.1002\/lt.25886","DOI":"10.1002\/lt.25886"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53.\tKnoll M, Lodish HF, Sun L. Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol 2015;11:151-160. https:\/\/doi.org\/10.1038\/nrendo.2014.229","DOI":"10.1038\/nrendo.2014.229"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54.\tChen G, Yu D, Nian X, Liu J, Koenig RJ, Xu B, Sheng L. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL). Sci Rep 2016;6:35531. https:\/\/doi.org\/10.1038\/srep35531","DOI":"10.1038\/srep35531"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55.\tSheng L, Ye L, Zhang D, Cawthorn WP, Xu B. New Insights Into the Long Non-coding RNA SRA: Physiological Functions and Mechanisms of Action. Front Med (Lausanne) 2018;5:244. https:\/\/doi.org\/10.3389\/fmed.2018.00244","DOI":"10.3389\/fmed.2018.00244"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56.\tLiu S, Sheng L, Miao H, Saunders TL, MacDougald OA, Koenig RJ, Xu B. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J Biol Chem 2014;289:13000-13009. https:\/\/doi.org\/10.1074\/jbc.M114.564658","DOI":"10.1074\/jbc.m114.564658"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57.\tWu B, Xu C, Tian Y, Zeng Y, Yan F, Chen A, Zhao J, Chen L. Aerobic exercise promotes the expression of ATGL and attenuates inflammation to improve hepatic steatosis via lncRNA SRA. Sci Rep 2022;12:5370. https:\/\/doi.org\/10.1038\/s41598-022-09174-0","DOI":"10.21203\/rs.3.rs-1035461\/v1"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58.\tWu B, Ding J, Chen A, Song Y, Xu C, Tian F, Zhao J. Aerobic exercise improves adipogenesis in diet-induced obese mice via the lncSRA\/p38\/JNK\/PPAR\u03b3 pathway. Nutr Res 2022;105:20-32. https:\/\/doi.org\/10.1016\/j.nutres.2022.04.004","DOI":"10.1016\/j.nutres.2022.04.004"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59.\tKim SW, Muise AM, Lyons PJ, Ro HS. Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J Biol Chem 2001;276:10199-10206. https:\/\/doi.org\/10.1074\/jbc.M010640200","DOI":"10.1074\/jbc.m010640200"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60.\tHang HA, Yang XY, Xiao YF. AMPK\u03b11 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochem Biophys Res Commun 2016;474:364-370. https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.111","DOI":"10.1016\/j.bbrc.2016.04.111"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"61.\tJin L, Wang M, Yang B, Ye L, Zhu W, Zhang Q, Lou S, Zhang Y, Luo W, Liang G. A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice. Int Immunopharmacol 2023;115:109587. https:\/\/doi.org\/10.1016\/j.intimp.2022.109587","DOI":"10.1016\/j.intimp.2022.109587"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"62.\tWu YK, Hu LF, Lou DS, Wang BC, Tan J. Targeting DUSP16\/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK. Biochem Biophys Res Commun 2020;524:142-149. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.037","DOI":"10.1016\/j.bbrc.2020.01.037"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"63.\tQu Z, Sun J, Zhang W, Yu J, Zhuang C. Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease. Free Radic Biol Med 2020;159:87-102. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.06.028","DOI":"10.1016\/j.freeradbiomed.2020.06.028"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"64.\tZhang CY, Hu XC, Zhang GZ, Liu MQ, Chen HW, Kang XW. Role of Nrf2 and HO-1 in intervertebral disc degeneration. Connect Tissue Res 2022;63:559-576. https:\/\/doi.org\/10.1080\/03008207.2022.2089565","DOI":"10.1080\/03008207.2022.2089565"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"65.\tYu H, Yan S, Jin M, Wei Y, Zhao L, Cheng J, Ding L, Feng H. Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy. Phytomedicine 2023;113:154746. https:\/\/doi.org\/10.1016\/j.phymed.2023.154746","DOI":"10.1016\/j.phymed.2023.154746"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"66.\tLi X, Cui W, Cui Y, Song X, Jia L, Zhang J. Stropharia rugoso-annulata acetylated polysaccharides alleviate NAFLD via Nrf2\/JNK1\/AMPK signaling pathways. Int J Biol Macromol 2022;215:560-570. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.06.156","DOI":"10.1016\/j.ijbiomac.2022.06.156"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"67.\tShen B, Wang Y, Cheng J, Peng Y, Zhang Q, Li Z, Zhao L, Deng X, Feng H. Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine 2023;109:154561. https:\/\/doi.org\/10.1016\/j.phymed.2022.154561","DOI":"10.1016\/j.phymed.2022.154561"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"68.\tHuang YH, Wang FS, Wang PW, Lin HY, Luo SD, Yang YL. Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice. Int J Mol Sci 2022;23:577. https:\/\/doi.org\/10.3390\/ijms23010577","DOI":"10.3390\/ijms23010577"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"69.\tTsai CC, Chen YJ, Yu HR, Huang LT, Tain YL, Lin IC, Sheen JM, Wang PW, Tiao MM. Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice. Lipids Health Dis 2020;19:105. https:\/\/doi.org\/10.1186\/s12944-020-01274-y","DOI":"10.1186\/s12944-020-01274-y"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"70.\tMazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, ET AL. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Des Devel Ther 2013;7:553-563. https:\/\/doi.org\/10.2147\/DDDT.S43930","DOI":"10.2147\/dddt.s43930"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"71.\tDi Naso FC, Porto RR, Fillmann HS, Maggioni L, Padoin AV, Ramos RJ, Mottin CC, Bittencourt A, Marroni NA, de Bittencourt PI Jr. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obesity (Silver Spring) 2015;23:120-129. https:\/\/doi.org\/10.1002\/oby.20919","DOI":"10.1016\/s0168-8278(14)60455-4"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"72.\tZhang J, Fan N, Peng Y. Heat shock protein 70 promotes lipogenesis in HepG2 cells. Lipids Health Dis 2018;17:73. https:\/\/doi.org\/10.1186\/s12944-018-0722-8","DOI":"10.1186\/s12944-018-0722-8"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"73.\tB\u0103l\u0103nescu A, Stan I, Codreanu I, Com\u0103nici V, B\u0103l\u0103nescu E, B\u0103l\u0103nescu P. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study. Dis Markers 2019;2019:9560247. https:\/\/doi.org\/10.1155\/2019\/9560247","DOI":"10.1155\/2019\/9560247"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"74.\tZheng ZG, Zhang X, Liu XX, Jin XX, Dai L, Cheng HM, Jing D, ET AL. Inhibition of HSP90\u03b2 Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System. Theranostics 2019;9:5769-5783. https:\/\/doi.org\/10.7150\/thno.36505","DOI":"10.7150\/thno.36505"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"75.\tMa B, Ju A, Zhang S, An Q, Xu S, Liu J, Yu L, Fu Y, Luo Y. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease. Signal Transduct Target Ther 2023;8:229. https:\/\/doi.org\/10.1038\/s41392-023-01437-0","DOI":"10.1038\/s41392-023-01437-0"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76.\tAkbulut T, Cinar V, Aydin S, Yardim M. The role of different exercises in irisin, heat shock protein 70 and some biochemical parameters. J Med Biochem 2022;41:149-155. https:\/\/doi.org\/10.5937\/jomb0-31551","DOI":"10.5937\/jomb0-31551"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"77.\tPatel H, Alkhawam H, Madanieh R, Shah N, Kosmas CE, Vittorio TJ. Aerobic vs anaerobic exercise training effects on the cardiovascular system. World J Cardiol 2017;9:134-138. https:\/\/doi.org\/10.4330\/wjc.v9.i2.134","DOI":"10.4330\/wjc.v9.i2.134"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"78.\tLiu S, Liu Y, Liu Z, Hu Y, Jiang M. A review of the signaling pathways of aerobic and anaerobic exercise on atherosclerosis. J Cell Physiol 2023;238:866-879. https:\/\/doi.org\/10.1002\/jcp.30989","DOI":"10.1002\/jcp.30989"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79.\tGa\u0161parini D, Kavazovi\u0107 I, Barkovi\u0107 I, Mari\u010di\u0107 V, Ivani\u0161 V, Samsa DT, Per\u0161i\u0107 V, Poli\u0107 B, Turk Wensveen T, Wensveen FM. Extreme anaerobic exercise causes reduced cytotoxicity and increased cytokine production by peripheral blood lymphocytes. Immunol Lett 2022;248:45-55. https:\/\/doi.org\/10.1016\/j.imlet.2022.06.001","DOI":"10.1016\/j.imlet.2022.06.001"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"80.\tRiboulet-Chavey A, Diraison F, Siew LK, Wong FS, Rutter GA. Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity. Diabetes 2008;57:415-423. https:\/\/doi.org\/10.2337\/db07-0993","DOI":"10.2337\/db07-0993"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"81.\tSemenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med 2011;365:537-547. https:\/\/doi.org\/10.1056\/NEJMra1011165","DOI":"10.1056\/nejmra1011165"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"82.\tKarhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004;114:1098-1106. https:\/\/doi.org\/10.1172\/JCI200421086","DOI":"10.1172\/jci200421086"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83.\tNeurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000;19:51-62. https:\/\/doi.org\/10.3109\/08830180009048389","DOI":"10.3109\/08830180009048389"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"84.\tCorrado C, Fontana S. Hypoxia and HIF Signaling: One Axis with Divergent Effects. Int J Mol Sci 2020;21:5611. https:\/\/doi.org\/10.3390\/ijms21165611","DOI":"10.3390\/ijms21165611"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"85.\tJu C, Colgan SP, Eltzschig HK. Hypoxia-inducible factors as molecular targets for liver diseases. J Mol Med (Berl) 2016;94:613-627. https:\/\/doi.org\/10.1007\/s00109-016-1408-1","DOI":"10.1007\/s00109-016-1408-1"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"86.\tMinamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol 2009;29:5729-5741. https:\/\/doi.org\/10.1128\/MCB.00331-09","DOI":"10.1128\/mcb.00331-09"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"87.\tChen J, Chen J, Huang J, Li Z, Gong Y, Zou B, Liu X, ET AL. HIF-2\u03b1 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway. Aging (Albany NY) 2019;11:10839-10860. https:\/\/doi.org\/10.18632\/aging.102488","DOI":"10.18632\/aging.102488"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"88.\tYu L, Wang H, Han X, Liu H, Zhu D, Feng W, Wu J, Bi Y. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2\u03b1. J Endocrinol 2020;246:57-67. https:\/\/doi.org\/10.1530\/JOE-19-0555","DOI":"10.1530\/joe-19-0555"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"89.\tMorello E, Sutti S, Foglia B, Novo E, Cannito S, Bocca C, Rajsky M, ET AL. Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein. Hepatology 2018;67:2196-2214. https:\/\/doi.org\/10.1002\/hep.29754","DOI":"10.1002\/hep.29754"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"90.\tMesarwi OA, Moya EA, Zhen X, Gautane M, Zhao H, Wegbrans Gir\u00f3 P, Alshebli M, ET AL. Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease. Am J Respir Cell Mol Biol 2021;65:390-402. https:\/\/doi.org\/10.1165\/rcmb.2020-0492OC","DOI":"10.1165\/rcmb.2020-0492oc"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"91.\tWang CH, Liu HM, Chang ZY, Huang TH, Lee TY. Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1\u03b1 in a Murine Model of NAFLD. Int J Mol Sci 2021;22:7841. https:\/\/doi.org\/10.3390\/ijms22157841","DOI":"10.3390\/ijms22157841"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"92.\tHe Y, Yang W, Gan L, Liu S, Ni Q, Bi Y, Han T, ET AL. Silencing HIF-1\u03b1 aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-\u03b1\/ANGPTL4 singling pathway. Gastroenterol Hepatol 2021;44:355-365. https:\/\/doi.org\/10.1016\/j.gastrohep.2020.09.014","DOI":"10.1016\/j.gastre.2020.09.005"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"93.\tArai T, Tanaka M, Goda N. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver. Sci Rep 2018;8:14230. https:\/\/doi.org\/10.1038\/s41598-018-32586-w","DOI":"10.1038\/s41598-018-32586-w"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"94.\tNava RC, McKenna Z, Fennel Z, Berkemeier Q, Ducharme J, de Castro Magalh\u00e3es F, Amorim FT, Mermier C. Repeated sprint exercise in hypoxia stimulates HIF-1-dependent gene expression in skeletal muscle. Eur J Appl Physiol 2022;122:1097-1107. https:\/\/doi.org\/10.1007\/s00421-022-04909-3","DOI":"10.1007\/s00421-022-04909-3"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"95.\tMuangritdech N, Hamlin MJ, Sawanyawisuth K, Prajumwongs P, Saengjan W, Wonnabussapawich P, Manimmanakorn N, Manimmanakorn A. Hypoxic training improves blood pressure, nitric oxide and hypoxia-inducible factor-1 alpha in hypertensive patients. Eur J Appl Physiol 2020;120:1815-1826. https:\/\/doi.org\/10.1007\/s00421-020-04410-9","DOI":"10.1007\/s00421-020-04410-9"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"96.\tDengler F. Activation of AMPK under Hypoxia: Many Roads Leading to Rome. Int J Mol Sci 2020;21:2428. https:\/\/doi.org\/10.3390\/ijms21072428","DOI":"10.3390\/ijms21072428"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:47:07Z","timestamp":1731415627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_671.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":96,"journal-issue":{"issue":"5\/2024","published-online":{"date-parts":[[2024,11,8]]}},"URL":"https:\/\/doi.org\/10.33549\/physiolres.935244","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}